{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:03:31Z","timestamp":1761541411460,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.brachy.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T20:48:26Z","timestamp":1509569306000},"page":"214-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Manual vs. automated implantation of seeds in prostate brachytherapy: Oncologic results from a single-center study"],"prefix":"10.1016","volume":"17","author":[{"given":"Laurence","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Chemin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0136-7165","authenticated-orcid":false,"given":"Sarah","family":"Belhomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lasbareilles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Descat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilhem","family":"Roubaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Sargos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.09.013_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.09.013_bib2","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/j.canrad.2016.07.038","volume":"20 Suppl","author":"Pommier","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2017.09.013_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.canrad.2014.05.014","article-title":"Results of a cohort of 200 hormone-naive consecutive patients with prostate cancer treated with iodine 125 permanent interstitial brachytherapy by the same multidisciplinary team","volume":"18","author":"Bolla","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2017.09.013_bib4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ijrobp.2007.11.056","article-title":"Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie\/Cochin Hospital\/Necker Hospital group on 809 patients","volume":"71","author":"Cosset","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2010.04.038","article-title":"10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results\u00a0for 1,100 patients","volume":"80","author":"Crook","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ijrobp.2010.11.049","article-title":"Prostate specific antigen bounce is related to overall survival in prostate brachytherapy","volume":"82","author":"Hinnen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijrobp.2009.01.078","article-title":"Local control following permanent prostate brachytherapy: Effect of high biologically effective dose on biopsy results and oncologic outcomes","volume":"76","author":"Stone","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2010.05.042","article-title":"Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I125 prostate brachytherapy in clinically localized prostate cancer: Seattle experience","volume":"81","author":"Sylvester","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijrobp.2009.02.021","article-title":"Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy","volume":"76","author":"Taira","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.radonc.2009.12.012","article-title":"Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy","volume":"94","author":"Polo","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.09.013_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.brachy.2014.01.009","article-title":"Placement of empty catheters for an HDR-emulating LDR prostate brachytherapy technique: Comparison to standard intraoperative planning","volume":"13","author":"Niedermayr","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.09.013_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8140(00)00306-6","article-title":"ESTRO\/EAU\/EORTC recommendations on permanent seed implantation for localized prostate cancer","volume":"57","author":"Ash","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.09.013_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0360-3016(99)00069-3","article-title":"American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer","volume":"44","author":"Nag","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.brachy.2017.09.013_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2007.01.014","article-title":"Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO\/EAU\/EORTC recommendations on prostate brachytherapy","volume":"83","author":"Salembier","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.09.013_bib16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canrad.2016.11.001","article-title":"Oncological and functional results of robotic salvage radical prostatectomy after permanent brachytherapy implants","volume":"21","author":"Orr\u00e9","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2017.09.013_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ijrobp.2013.08.010","article-title":"Conventional versus automated implantation of loose seeds in prostate brachytherapy: Analysis of dosimetric and clinical results","volume":"87","author":"Genebes","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijrobp.2009.01.050","article-title":"Outcomes following iodine-125 monotherapy for localized prostate cancer: The results of Leeds 10-year single-center brachytherapy experience","volume":"76","author":"Henry","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13014-015-0349-0","article-title":"Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review","volume":"10","author":"Zuber","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2017.09.013_bib22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2014.08.340","article-title":"A dose-response analysis of biochemical control outcomes after 125I monotherapy for patients with favorable-risk prostate cancer","volume":"90","author":"Shiraishi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brachy.2013.08.006","article-title":"Whole prostate D90 and V100: A dose-response analysis of 2000 consecutive 125I monotherapy patients","volume":"13","author":"Morris","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.09.013_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(98)00006-6","article-title":"A dose-response study for I-125 prostate implants","volume":"41","author":"Stock","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2005.07.981","article-title":"Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results","volume":"64","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brachy.2013.11.009","article-title":"Does dose matter? Editorial comments to Morris et\u00a0al. Whole prostate D90 and V100: A dose-response analysis of 2000 consecutive 125I monotherapy cases","volume":"13","author":"Stone","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.09.013_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/030089161309900114","article-title":"125I brachytherapy for localized prostate cancer: A single institution experience","volume":"99","author":"Guarneri","year":"2013","journal-title":"Tumori"},{"key":"10.1016\/j.brachy.2017.09.013_bib28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00345-013-1148-6","article-title":"PSA-nadir at 1 year as a sound contemporary prognostic factor for low-dose-rate iodine-125 seeds brachytherapy","volume":"32","author":"Reis","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.brachy.2017.09.013_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0100-39842014000200010","article-title":"Relationship between two year PSA nadir and biochemical recurrence in prostate cancer patients treated with iodine-125 brachytherapy","volume":"47","author":"Franca","year":"2014","journal-title":"Radiol Bras"},{"key":"10.1016\/j.brachy.2017.09.013_bib30","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.brachy.2015.09.005","article-title":"Prostate-specific antigen bounce after curative brachytherapy for early-stage prostate cancer: A study of 274 African-Caribbean patients","volume":"14","author":"Leduc","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.09.013_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brachy.2006.02.003","article-title":"PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: A study of 295 patients with a minimum 3-year followup","volume":"5","author":"Toledano","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.09.013_bib32","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ijrobp.2005.07.960","article-title":"PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for\u00a0PSA doubling time","volume":"64","author":"Ciezki","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.09.013_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00066-015-0860-0","article-title":"PSA bounce after 125I-brachytherapy for prostate cancer as a favorable prognosticator","volume":"191","author":"Engeler","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2017.09.013_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.urology.2003.08.025","article-title":"PSA bounce predicts early success in patients with permanent iodine-125 prostate implant","volume":"63","author":"Patel","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2017.09.013_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/COC.0b013e3181ec63c5","article-title":"Analysis of seed loss and pulmonary seed migration in patients treated with virtual needle guidance and robotic seed delivery","volume":"34","author":"Hathout","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.09.013_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2006.06.004","article-title":"Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer","volume":"80","author":"Guedea","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.09.013_bib37","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.eururo.2011.06.044","article-title":"Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: A systematic review of randomised and nonrandomised controlled clinical trials","volume":"60","author":"Peinemann","year":"2011","journal-title":"Eur Urol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:12:48Z","timestamp":1761531168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117304713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1538472117304713"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.09.013","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manual vs. automated implantation of seeds in prostate brachytherapy: Oncologic results from a single-center study","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}